Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Molecular and Cellular Biology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About MCB
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Articles

EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance

Carla Danussi, Lisa Del Bel Belluz, Eliana Pivetta, Teresa Maria Elisa Modica, Andres Muro, Bruna Wassermann, Roberto Doliana, Patrizia Sabatelli, Alfonso Colombatti, Paola Spessotto
Carla Danussi
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lisa Del Bel Belluz
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliana Pivetta
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa Maria Elisa Modica
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andres Muro
bInternational Centre for Genetic Engineering and Biotechnology, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruna Wassermann
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roberto Doliana
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrizia Sabatelli
cCNR-National Research Council of Italy, IGM-IOR, Bologna, Italy
dSC Laboratory of Muscoloskeletal Cell Biology, IOR, Bologna, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alfonso Colombatti
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
eDepartment of Medical and Biomedical Sciences, University of Udine, Udine, Italy
fMATI (Microgravity, Ageing, Training, Immobility) Excellence Center, University of Udine, Udine, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Spessotto
aExperimental Oncology 2, CRO, IRCCS, National Cancer Institute, Aviano (PN), Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/MCB.00872-13
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Fig 1
    • Open in new tab
    • Download powerpoint
    Fig 1

    Expression of EMILIN1 in developing and mature lymphatic valves. Shown is immunofluorescence staining of mesenteric lymphatic vessels (A, B, and C) and adult ear skin (D) with antibodies against Prox1 (green) and EMILIN1 (pseudocolored gray or red). Representative images from tissues taken from embryos at the indicated ages (A and B) and from the postnatal period (P0 [C] and P21 [D]) are shown. The arrows in panel B indicate more evident staining for EMILIN1 associated with endothelial cells expressing high levels of Prox1. The dotted line outlines the lymphatic vessels. Z-sections of mesenteric lymphatic vessels and the corresponding x and y projections showing a clear association between EMILIN1 and Prox-1 staining are provided for panels A, B, and C. Scale bars, 100 μm.

  • Fig 2
    • Open in new tab
    • Download powerpoint
    Fig 2

    Abnormal lymphatic valves in Emilin1−/− mice. (A) PECAM-1 immunohistochemistry of mesenteric vessels and luminal valves of embryonic (E16.5 and E18.5) and postnatal (P0, P3, and P6) WT and Emilin1−/− mice. Note the difference in shape of WT (arrowheads) and Emilin1−/− (arrows) valves. (B) Luminal valves in chyle-filled mesenteric P6 WT and Emilin1−/− mice. The arrows and arrowheads indicate abnormal (ring-shaped) and normal (V-shaped) valves, respectively. (C) Morphological evaluation of valve shape in P6 WT and Emilin1−/− mesenteric lymphatic vessels. Black bar, normal V-shaped valves; white bar, abnormal ring-shaped valves (n = 3 animals per genotype; more than 100 valves were counted for each genotype). *, P < 0.05 (χ2 test). (D and E) Quantification of the luminal valves in neonatal and postnatal WT and Emilin1−/− mesenteric lymphatic vessels of CD1 (P0 and P6) (D) and C57BL/6 (P0 and P6) (E) mice (means and standard deviations [SD]; n = 3 animals per genotype with 10 vessels each; *, P < 0.05; **, P < 0.01; unpaired Student's t test). Scale bars, 50 μm (A) and 100 μm (B).

  • Fig 3
    • Open in new tab
    • Download powerpoint
    Fig 3

    Defects of lymphatic collectors in adult animals. (A) Quantification of the luminal valves in adult (P21) CD1 WT and Emilin1−/− mesenteric lymphatic vessels (means and SD; n = 3 animals per genotype with 10 vessels each; *, P = 0.01). (B) PECAM-1 staining of ear vessels in 6-month-old C57BL/6 mice. Note the well-formed V-shaped valves in WT animals compared to the narrow structures of collecting vessels in Emilin1−/− mice. (C) Adult lymphatic mesenteric vessels (P21) stained for α-SMA (gray) and Prox1 (green) of WT and Emilin1−/− mice. (D) Lumen sizes of the valves in adult (P21) WT and Emilin1−/− mesenteric lymphatic vessels. Z-stack images were collected from whole-mount samples stained for α-SMA and Prox1; the resulting three-dimensional (3D) reconstruction by Volocity software combined with x and y projections was used to highlight and calculate the smallest (ds) and largest (dl) diameters of the valve lumen. The values obtained from calculation [(ds + dl)/2] are reported in the graph. Four mice per genotype (at least 5 valves/mesentery) were examined. *, P < 0.01. Scale bars, 25 μm (C) and 50 μm (B).

  • Fig 4
    • Open in new tab
    • Download powerpoint
    Fig 4

    Abnormal lymphatic collectors and valves in Emilin1−/− adult mice. Shown are serial semithin cross sections of P21 WT (A) and two representative Emilin1−/− (B and C) mesenteric valves. Note the increased thickness of the lymphatic wall in Emilin1−/− mice. The lumen of collecting vessels in the right-hand panel appears contracted, with folded valve leaflets. The sections marked “a” in panels A and C were subjected to ultrastructural analysis as shown in Fig. 5. Scale bars, 25 μm.

  • Fig 5
    • Open in new tab
    • Download powerpoint
    Fig 5

    Ultrastructural analysis of mesenteric valves and lymphatic wall in adult mice. (A and B) TEM analysis of P21 WT (A) and Emilin1−/− (B) mesenteric valves. The colored boxes in the semithin sections (upper left panels, corresponding to sections Aa and Ca, respectively, from Fig. 4) represent the areas that were selected for ultrathin sections. Emilin1−/− mice show an increased number of mural cells/pericytes (P), which display a SMC/myofibroblast-like phenotype, and folded LECs. The arrow in panel B indicates a mitotic LEC. (C) TEM analysis of P21 WT and Emilin1−/− mesenteric lymphatic vessel walls showing increased numbers of caveolae (arrows) and cytoplasmic filaments (F) and the presence of a basement membrane (arrowheads) at the surface of one representative Emilin1−/− mural cell/pericyte. Scale bars, 25 μm (Aa and Ba), 1 μm (A and B), and 500 nm (C).

  • Fig 6
    • Open in new tab
    • Download powerpoint
    Fig 6

    EMILIN1 deficiency leads to impaired lymphatic collector function. FITC-dextran (2,000 kDa) was subcutaneously injected into the tails of WT and Emilin1−/− mice at P21 (A) and at 6 weeks (B) to visualize the draining lymphatic vasculature and lymph nodes. The mice were sacrificed after injection at the indicated times. Low-magnification images were taken to visualize lymph nodes, and high-magnification images (a, a′, a″, a‴, b, and b′) were taken to detail collectors corresponding to the boxed areas. Note the difference in fluorescence intensity between WT and Emilin1−/− draining lymph nodes and collectors. The arrows and arrowheads indicate V- and ring-shaped valves, respectively. (C) Draining lymph nodes (inguinal, iliac, and mesenteric) were removed 30 min after injection and measured with a computer-interfaced GeniusPlus microplate reader (Tecan, Italy). Arbitrary fluorescence units (AU) in the graph represent the sums obtained from the fluorescence values of all draining lymph nodes/mouse. The graph reports the means ± SD of three independent experiments (n = 4 animals per genotype). Scale bar, 2 mm (0.5 mm in a, a′, a″, a‴, b, and b′).

  • Fig 7
    • Open in new tab
    • Download powerpoint
    Fig 7

    EMILIN1 colocalizes with α9 integrin in valve leaflets. Immunofluorescence staining for the localization of EMILIN1 (green) and α9 integrin (A′, red or gray) in embryonic (E18.5) (A and A′), neonatal (P0) (B, C, and D), and mature (P6) (E) mesenteric lymphatic vessels. The arrows indicate lymphatic valves, which were positive for both EMILIN1 and α9 integrin staining. (C) Magnification of the boxed area in panel B. The dotted lines in panel A outline the lymphatic vessels. (B and C) Mesenteric vessels are indicated as follow: a, artery; v, vein; l, lymphatic. (D) Four confocal longitudinal cross sections of a mesenteric valve showing EMILIN1 expression at both abluminal (z1) and luminal (z2, z3, and z4) sides of the valve and colocalization with α9 integrin in the valve leaflets. (E) Representative P6 mesenteric lymphatic valve stained for EMILIN1 (green) and α9 integrin (red). Scale bars, 150 μm (B), 50 μm (A, C, and D), and 25 μm (E).

  • Fig 8
    • Open in new tab
    • Download powerpoint
    Fig 8

    EMILIN1 is an α9 integrin-specific ligand in the lymphatic vasculature system. (A) Percentages of HMVEC-LLy and HMVEC-dLyNeo cells adhering to EMILIN1 (E1), gC1q, E933A, and bovine serum albumin (BSA). The data are expressed as means and SD of three independent experiments with 6 replicates. (B) Adhesion of HMVEC-LLy and Jurkat cells (positive control for α4 integrin expression). The cells were preincubated with anti-α4 integrin subunit monoclonal antibody (MAb) (P1H4) or anti-α9 integrin subunit MAb (Y9A2). The data are expressed as means and SD of three independent experiments with 6 replicates. (C) Proliferation of HMVEC-LLy cells cultured on tissue culture plates (plastics) and incubated for 48 h in the presence of fibronectin, EIIIA, E1, or gC1q. The data are expressed as mean percentages and SD of the number of Ki67-positive cells of three independent experiments. Six fields were examined for each condition. (D) Representative images of Ki67 (green) and α-SMA (red) staining of WT and Emilin1−/− P6 mesenteric vessels. The dotted lines outline the lymphatic vessels. The insets are magnifications of the boxed areas showing the presence of a higher number of Ki67-positive cells in Emilin1−/− lymphatic valves. (E) Quantification of the Ki67-positive cells of luminal valve-associated areas in WT and Emilin1−/− P6 mesenteric lymphatic vessels. Z-stack images were collected from whole-mount samples; the resulting 3D reconstruction by Volocity software was used to highlight and calculate the valve area and count the associated Ki67-positive cells. Four mice per genotype (at least 10 valves/mesentery) were examined. (F) Haptotactic movement of HMVEC-dLyNeo cells toward gC1q or EIIIA in the presence or absence of the function-blocking monoclonal anti-α9 integrin subunit. (G) Phalloidin staining for actin cytoskeleton visualization of HMVEC-dLyNeo after 1 h of adhesion on FN, EMILIN1, EIIIA, or gC1q. (H) Wound-healing scratch performed on HMVEC-dLyNeo in the presence of the function-blocking monoclonal anti-α9 integrin subunit or of the monoclonal antibody anti-gC1q. Scratch healing was determined by measuring the shortest distance between scratch edges at 0 and 20 h in each field of view. At least 3 different fields were measured per scratch. (I and J) Wound-healing assays of WT and Emilin1−/− (E1-/-) LAECs. The graphs report the speed of closure (μm/h) of WT and Emilin1−/− LAECs in the presence of culture medium without (I) or enriched with (J) supplements and growth factors. (K) Immunodetection for EMILIN1 staining of LAEC transduced with scrambled or short hairpin RNA EMILIN1 (shEMILIN1) lentiviral particles. (L and M) Velocity of scrambled (scr) and EMILIN1 silenced (shE1) LAECs in a scratch assay in the presence of culture medium without (L) or enriched with (M) supplements and growth factors. The data shown in the graphs are the means and SD of three independent experiments each. *, P < 0.05; **, P ≤ 0.02; ***, P = 0.0001. Scale bars, 50 μm (D, G, and K) and 25 μm (insets).

  • Fig 9
    • Open in new tab
    • Download powerpoint
    Fig 9

    EMILIN1 and FN-EIIIA contributions to valve formation and maturation. Fn-EIIIA-null mice were crossed with Emilin1-null mice. The luminal valve numbers (A and B) and morphological analyses (C and D) of mesenteric lymphatic vessels in neonatal (P0) (A and C) and postnatal (P6) (B and D) mice of the resulting genotypes are reported in the graphs. (E) Mesenteric vessels stained for PECAM-1 of P0 and P6 WT (E1+/+ EIIIA+/+), E1+/+ EIIIA−/−, E1−/− EIIIA+/+, and double-KO (E1−/− EIIIA−/−) mice. The arrowheads and arrows indicate normal V-shaped and abnormal ring-shaped valves, respectively. (F) Morphological analyses of semithin (top) and ultrathin (bottom) cross sections of mesenteric collecting vessels of E1+/+ EIIIA−/− mice at P21 showing normal features of the valve leaflets (VL), endothelial cells (LEC), and mural cells/pericytes (P). The data shown in panels A and B are the means and SD (n = 3 to 6 animals per genotype with more than 10 vessels each). The data in panels C and D were obtained from 3 to 6 animals per genotype (more than 100 valves each). #, P = 0.05; *, P < 0.05; **, P < 0.01 (a one-way analysis of variance followed by Tukey's post hoc test was performed). Scale bars, 50 μm (E), 20 μm (F, top), and 1 μm (F, bottom).

PreviousNext
Back to top
Download PDF
Citation Tools
EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance
Carla Danussi, Lisa Del Bel Belluz, Eliana Pivetta, Teresa Maria Elisa Modica, Andres Muro, Bruna Wassermann, Roberto Doliana, Patrizia Sabatelli, Alfonso Colombatti, Paola Spessotto
Molecular and Cellular Biology Oct 2013, 33 (22) 4381-4394; DOI: 10.1128/MCB.00872-13

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Molecular and Cellular Biology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance
(Your Name) has forwarded a page to you from Molecular and Cellular Biology
(Your Name) thought you would be interested in this article in Molecular and Cellular Biology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
EMILIN1/α9β1 Integrin Interaction Is Crucial in Lymphatic Valve Formation and Maintenance
Carla Danussi, Lisa Del Bel Belluz, Eliana Pivetta, Teresa Maria Elisa Modica, Andres Muro, Bruna Wassermann, Roberto Doliana, Patrizia Sabatelli, Alfonso Colombatti, Paola Spessotto
Molecular and Cellular Biology Oct 2013, 33 (22) 4381-4394; DOI: 10.1128/MCB.00872-13
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About MCB
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #MCBJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0270-7306; Online ISSN: 1098-5549